Thats the plan, I don't invest money I can't afford to lose or can't afford to go without for a period time. Kaly has a huge leg up on its competiton and Im sure someone will want what they have, this sector is just getting started. Once they become current, huge companies will want to buy them out for the patent alone. which should be worth more than 5+ dollars per share. But we will see. Patient money turns into big money.
News 
Market Data 
Discover 
